A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycanJihee Kim, Yung‐Yao Lin, Francesco Catapano et al.|EMBO Reports|2019Cited by 23
Targeted gene correction of <i>FKRP</i> by CRISPR/Cas9 restores functional glycosylation of α-dystroglycan in cortical neurons derived from human induced pluripotent stem cellsBeatrice Lana, Yung‐Yao Lin, Jihee Kim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 0